Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01947608
Title Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
Recruitment No longer available
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

lung non-small cell carcinoma

Therapies

Ceritinib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST